Core Laboratories NV (CLB) Tops Q3 EPS by 2c; Issues Light Q4 Outlook
Tweet
Share
E-mailGet Alerts CLB Hot Sheet
Price: $12.39 -0.48%
Financial Fact:
Net income attributable to Core Laboratories N.V.: 16.73M
Today's EPS Names:
OFLX, VAXX, NMRD, More
Financial Fact:
Net income attributable to Core Laboratories N.V.: 16.73M
Today's EPS Names:
OFLX, VAXX, NMRD, More
Join SI Premium – FREE
Core Laboratories NV (NYSE: CLB) reported Q3 EPS of $1.53, $0.02 better than the analyst estimate of $1.51. Revenue for the quarter came in at $276.14 million versus the consensus estimate of $284.3 million.
Core Laboratories NV sees Q4 2014 EPS of $1.53-$1.56, versus the consensus of $1.6. Core Laboratories NV sees Q4 2014 revenue of $275-280 million, versus the consensus of $292.8 million.
For earnings history and earnings-related data on Core Laboratories NV (CLB) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Blackhawk Network (HAWK) Reports Q2 Loss of $0.07; Offers Guidance
- KULR Technology Group (KULR) Misses Q2 EPS by 39c
- CaliberCos Inc (CWD) Misses Q2 EPS by 43c; Offers Guidance
Create E-mail Alert Related Categories
Earnings, Guidance, Hot GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
